These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 17601050)
21. A sensitive and specific lateral flow assay for rapid detection of antibodies against glycoprotein B of Aujeszky's disease virus. Vrublevskaya VV; Afanasyev VN; Grinevich AA; Skarga YY; Gladyshev PP; Ibragimova SA; Krylsky DV; Dezhurov SV; Morenkov OS J Virol Methods; 2017 Nov; 249():175-180. PubMed ID: 28919034 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of parenteral vaccination methods with glycoproteins against Aujeszky's disease in pigs. Vanderpooten A; Goddeeris B; De Roose P; Hendrickx L; Biront P; Desmettre P Vet Microbiol; 1997 Apr; 55(1-4):81-9. PubMed ID: 9220599 [TBL] [Abstract][Full Text] [Related]
23. Identification of the pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodies. Eloit M; Fargeaud D; L'Haridon R; Toma B Arch Virol; 1988; 99(1-2):45-56. PubMed ID: 2833202 [TBL] [Abstract][Full Text] [Related]
24. Herpes simplex virus glycoprotein D. Protective immunity against murine herpetic keratitis. Inoue Y; Ohashi Y; Shimomura Y; Manabe R; Yamada M; Ueda S; Kato S Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):411-8. PubMed ID: 2318582 [TBL] [Abstract][Full Text] [Related]
25. Protection from pseudorabies virus challenge in mice by a combination of purified gII, gIII and gVI antigens. Matsuda Tsuchida A; Katayama S; Okada N; Okabe T; Sasaki N J Vet Med Sci; 1992 Jun; 54(3):447-52. PubMed ID: 1322712 [TBL] [Abstract][Full Text] [Related]
26. Measurement of isotype-specific antibody responses to Aujeszky's disease virus in sera and mucosal secretions of pigs. Kimman TG; Brouwers RA; Daus FJ; van Oirschot JT; van Zaane D Vet Immunol Immunopathol; 1992 Feb; 31(1-2):95-113. PubMed ID: 1315087 [TBL] [Abstract][Full Text] [Related]
27. Local humoral and cellular responses in Aujeszky's disease virus infection in pigs. Martin S; Wardley RC Res Vet Sci; 1987 Mar; 42(2):170-4. PubMed ID: 3035662 [TBL] [Abstract][Full Text] [Related]
28. Protection of mice and swine from pseudorabies virus-induced mortality by administration of pseudorabies virus-specific mouse monoclonal antibodies. Marchioli C; Yancey RJ; Timmins JG; Post LE; Young BR; Povendo DA Am J Vet Res; 1988 Jun; 49(6):860-4. PubMed ID: 2840843 [TBL] [Abstract][Full Text] [Related]
29. Comparison of different prime-boost regimes with DNA and recombinant Orf virus based vaccines expressing glycoprotein D of pseudorabies virus in pigs. van Rooij EM; Rijsewijk FA; Moonen-Leusen HW; Bianchi AT; Rziha HJ Vaccine; 2010 Feb; 28(7):1808-13. PubMed ID: 20018271 [TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing. Raux H; Coulon P; Lafay F; Flamand A Virology; 1995 Jul; 210(2):400-8. PubMed ID: 7542418 [TBL] [Abstract][Full Text] [Related]
31. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I. van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288 [TBL] [Abstract][Full Text] [Related]
32. DNA priming and killed virus boosting vaccination strategy can augment the immune response to pseudorabies virus. Chen ZH; Guo X; Ge XN; Jia H; Yang HC Acta Virol; 2007; 51(3):163-70. PubMed ID: 18076306 [TBL] [Abstract][Full Text] [Related]
33. Role of glycoproteins of pseudorabies virus in eliciting neutralizing antibodies. Ben-Porat T; DeMarchi JM; Lomniczi B; Kaplan AS Virology; 1986 Oct; 154(2):325-34. PubMed ID: 2429441 [TBL] [Abstract][Full Text] [Related]
34. Induction of antibodies to pseudorabies virus by immunization with antiidiotypic antibodies. Gurish MF; Ben-Porat T; Nisonoff A Ann Inst Pasteur Immunol; 1988; 139(6):677-87. PubMed ID: 2849957 [TBL] [Abstract][Full Text] [Related]
35. Characterization of several pseudorabies viral strains by virus-neutralization test using monoclonal antibodies. Nosetto EO; Echeverria MG; Horimoto T; Pecoraro MR; Galosi CM; Tohya Y; Norimine J; Takahashi E; Etcheverrigaray ME; Mikami T Viral Immunol; 1997; 10(3):159-64. PubMed ID: 9344338 [TBL] [Abstract][Full Text] [Related]
36. Experimental vaccination of rabbits with non-pathogenic strains of Aujeszky's disease virus. Romero CH; Flores RS; Brentano L; Rowe CA Braz J Med Biol Res; 1989; 22(3):357-64. PubMed ID: 2553179 [TBL] [Abstract][Full Text] [Related]
37. Biologically safe, non-transmissible pseudorabies virus vector vaccine protects pigs against both Aujeszky's disease and classical swine fever. Peeters B; Bienkowska-Szewczyk K; Hulst M; Gielkens A; Kimman T J Gen Virol; 1997 Dec; 78 ( Pt 12)():3311-5. PubMed ID: 9400982 [TBL] [Abstract][Full Text] [Related]
38. Monoclonal blocking ELISA detecting serum antibodies to the glycoprotein gII of Aujeszky's disease virus. Qvist P; Sørensen KJ; Meyling A J Virol Methods; 1989; 24(1-2):169-79. PubMed ID: 2547813 [TBL] [Abstract][Full Text] [Related]
39. Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies. Liu DX; Gompels UA; Foa-Tomasi L; Campadelli-Fiume G Virology; 1993 Nov; 197(1):12-22. PubMed ID: 7692666 [TBL] [Abstract][Full Text] [Related]
40. Intranasal vaccination of pigs against Aujeszky's disease: comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres. Van Oirschot JT Res Vet Sci; 1987 Jan; 42(1):12-6. PubMed ID: 3029845 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]